期刊文献+

HLH-2004方案诊断治疗小儿噬血细胞综合征结果分析 被引量:7

Diagnosis and treatment of hemophagocytic lymphohistiocytosis in children with HLH-2004 protocol
暂未订购
导出
摘要 目的了解我国小儿噬血细胞综合征(HLH)的发病情况和治疗效果,并开展HLH的穿孔素(perforin)基因研究。方法研究对象为符合国际组织细胞协会HLH-2004诊断标准的18例患儿,分析患儿起病时及治疗后的临床资料。用流式细胞仪和基因测序法检测患儿的穿孔素基因。结果流式细胞仪检测发现1例患儿的穿孔素在CD8+T细胞和NK细胞中的表达几乎完全缺如,而且基因测序发现该患儿的穿孔素基因存在错义突变(G47C),确诊为原发性HLH。14例接受HLH-2004治疗,随访时间2周~39个月,临床缓解4例,复发4例,持续活动4例,失访2例。共死亡7例。结论HLH-2004是诊断和治疗小儿HLH的有效方案,提高生存率需积极开展造血干细胞移植。为鉴别原发性和继发性HLH应进行相关基因检测。 Objective Hemophagoeytic lymphohistiocytosis (HLH) is a pediatric disease with high mortality. In China, there are few studies on long-term follow-up based on standard diagnosis and treatment of HLH, and the reports on genetic diagnosis of HLH are absent. This study aimed to explore the therapeutic effect of HLH in children in China diagnosed and treated by HLH-2004 protocol announced by Histioeyte Society and to conduct the pefforin gene research in HLH. Methods Eighteen children aged 9 months to 10 years (12 males and 6 females) based on the diagnostic eriteria of HLH-2004 were enrolled. Their elinical materials were collected and analyzed at the onset of HLH and after therapy. The HLH-ehildren's pefforin genes were studied by flow eytometry and gene sequencing. Results Pefforin gene detection: the flow eytometry assay found that the expressions of perforin in CD8^+T cell and NK cell of one patient were nearly absent, furthermore a missense mutation (G47C) of pefforin gene was identified in this patient through gene sequencing, thus the primary/familial HLH was diagnosed. Therapeutic effect: 14 cases received HLH-2004 therapy, follow-up time ranged from 2 weeks to 39 months. Hemopoietic stem cell transplantation did not adopt in this research yet. Four cases achieved clinical remission, while 4 cases suffered from reactivations and continuous activations respectively, and 2 cases dropped off. Totally 7 cases died. Conclusions HLH-2004 protocol has an effect on the diagnosis and treatment of HLH in children. Hemopoietie stem cell transplantation should be conducted actively so as to increase the survival rate. Genetic study is a good way to differentiate primary HLH from secondary HLH.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2009年第8期718-722,共5页 Journal of Clinical Pediatrics
基金 复旦大学青年科学基金项目资助(No.JKF156002)
关键词 噬血细胞综合征 儿童 基因诊断 穿孔素 hemophagoeytie lymphohistiocytosis children genetic diagnosis perforin
  • 相关文献

参考文献10

  • 1Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis [J]. Hematol Am Soc Hematol Educ Program, 2005 : 82-88.
  • 2Henter JI, Samuelsson-Home A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation [J].Blood, 2002,100(7):2367-2373.
  • 3Henter JI, Home A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer, 2007, 48 (2) : 124-131.
  • 4Kogawa K, Lee SM, Villanueva J, et al. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members [J]. Blood, 2002,99( 1 ) :61-66.
  • 5Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histio cytic syndromes [JJ. Blood, 1989,73(8) :2128-2132.
  • 6Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis[J]. Science, 1999,286(5446) : 1957-1959.
  • 7Katono H, Cohen JI. Perforin and lymphohistioeytosis proliferative disorders [J]. Br J Haemetol,2005,128 (6) : 739-750.
  • 8Janka GE. Familial hemophagocytic lymphohistiocytosis [J]. Eur J Pediatr, 1983,140(3) :221-230.
  • 9谢静,张大伟,杨双.国际组织细胞协会HLH-2004方案治疗噬血细胞综合征疗效观察[J].中国实用儿科杂志,2006,21(8):629-630. 被引量:15
  • 10Horne A, Trottestam H, Aricb M, et al. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis [J]. Br J Haematol, 2008,140(3 ) : 327-335.

二级参考文献11

  • 1Henter JI,Elinder G,Ost A,et al.Diagnostic guideline for hemophagocytic lymphohistiocytosis[J].Semin Oncol,1991,18(1):29.
  • 2Henter JI.Biology and treatment of familial hemophagocytic lymphohistiocytosis:important of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis[J].J Med Pediatr Oncol,2002,38(5):305-309.
  • 3Su IJ,Chen RL,Lin DT,et al.Epstein-Barr virus(EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan[J].Am J Pathol,1994,144:1219-1225.
  • 4Stephan JL,Donadieu J,Le Deist F,et al.Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins,steroids and cyclosporin A[J].Blood,1993,82:2319-2323.
  • 5Fadeel B,Orrenius S,Henter JI.Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients[J].Brit J Haematol,1999,106:406-415.
  • 6Stepp SE,Dufourcq-Lagelouse R,Le Deist F,et al.Perforin gene defects in familial hemophagocytic lymphohistiocytosis[J].Science,1999,286:1957-1959.
  • 7Fadeel B,Orrenius S,Henter JI.Familial hemophagocytic lymphohistiocytosis:too little cell death may seriously damage your health[J].Leuk Lymphoma,2001,42:13-20.
  • 8Martinsson P,Liminga G,Nygren P,et al.Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell line[J].Anticancer Drugs,2001,12:699-705.
  • 9Graham GE,Graham LM,Bridge PJ,et al.Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis[J].Pediatr Res,2000,48:227-232.
  • 10Fedmann J,Callebaut I,Raposo G,et al.Munc 13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)[J].Cell,2003,115(4);461-473.

共引文献14

同被引文献43

  • 1王学文.噬血细胞性淋巴组织细胞增生症的诊断和治疗策略[J].东南国防医药,2009,11(1):40-44. 被引量:5
  • 2芮凤,邵剑明,谢晏如.噬血细胞综合征误诊为伤寒1例报道[J].浙江临床医学,2006,8(8):875-875. 被引量:1
  • 3FARQUHAR JW, CLAIREAUX AE. Familial haemophagocytic reticulosis. Arch Dis Child, 1952,27 (136) :519-525.
  • 4Henter JI, Home A, Aric6 M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer,2007,48(2) :124-131.
  • 5Knovich MA, Storey JA, Coffman LG, et al. Ferritin for the clinician. Blood Rev ,2009,23 ( 3 ) :95-104.
  • 6ViUanueva J, Lee S, Giannini EH, et al. Natural killer cell dys- function is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther,2005,7 (1) :R30-37.
  • 7Filipovich AH. Hemophagocytic lymphohistiocytosis ( HLH ) and related disorders. Hematology Am Soc Hematol Educ Program, 2009 : 127 -131.
  • 8Janka GE. Hemophagocytic syndromes. Blood Rev, 2007,21 (5) :245-253.
  • 9lmashuku S,Kufiyama K,Teramura T,et al. Requirement for etopo- side in the Irealment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol,2001,19(10) :2665-2673.
  • 10Henter JI,Samuelsson-Home A, Aricb M, et al. Treatment of he- mophagocytic lymphohisfiocytosis with HLH 94 irranunochernothera- py and bone marrow transplantation. Blood,2002,100(7) :2367-2373.

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部